Please assess the completion status of the following clinical trial:

Trial Title: Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* To be of legal age~* Having suffered from primary breast cancer with histological confirmation (I-IIIA)~* Completion of primary carcinoma treatment (surgery, chemotherapy, radiotherapy)~* To be receiving hormone therapy as an adjunct to the process by aromatase inhibitors (exemestane, anastrozole, letrozole)~* To present a functional status according to WHO from 0 (asymptomatic, complete and ambulatory activity) or 1 (symptomatic but completely ambulatory, strenuous physical activity restricted but able to perform sedentary gentle activities)~* To understand correctly Spanish~* To show their approval by signing the informed consent~* Having had musculoskeletal disorders attributable to IA.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Neuromuscular taping (Type: EXPERIMENTAL): The first group will receive a decalogue of healthy tips (general, to lead an active life) based on the best available evidence, and several strips of neuromuscular bandage will be applied on areas that refer pain (cervical, lumbosacral, both or wrist-forearm).
- No Kinesio taping (Type: NO_INTERVENTION): No Kinesio taping

Based on this trial design, predict the completion outcome and termination type (if applicable).